1 year return (CAGR)
26.19%
BB Biotech AG Exchange (SW, CHF)
BION.SW
49.15
+1.35 (+2.82%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
6.19%
5 year return (CAGR)
-9.56%
10 year return (CAGR)
-0.27%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
2.71B
Price/Sales
18.57
Ent value
2.51B
Price/Book
0.88
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-82.24%
Trailing P/E
2.01
PEG
-
Forward P/E
-
EPS growth
-3.42%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 48.20 |
| Daily high | 49.15 |
| Daily low | 48.20 |
| Daily Volume | 92K |
| All-time high | 179.00 |
| 1y analyst estimate | 69.00 |
| Beta | 0.67 |
| EPS (TTM) | 24.46 |
| Dividend per share | 0.00 |
| Ex-div date | 23 Mar 2026 |
| Next earnings date | 20 Feb 2026 |
Downside potential
Loading...
Downside potential data
| BION.SW | S&P500 | |
| Current price drop from All-time high | -72.54% | -0.07% |
| Highest price drop | -85.89% | -56.47% |
| Date of highest drop | 9 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -57.49% | -10.66% |
| Avg time to new high | 30 days | 12 days |
| Max time to new high | 3171 days | 1805 days |
News
BOSTON, October 13, 2026--SOUFFLÉ THERAPEUTICS, INC. ("Soufflé™" or "Company"), a leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthi...
October 13, 2026
Johnson & Johnson says it is working to improve results in its medical-device business, where surgery revenue fell for the latest quarter.
October 13, 2026
Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company focused on innovative drug discovery and development in immuno-oncology (IO), announced that Ming Wang (CEO) will participate in Bo...
October 13, 2026
Winnipeg, Manitoba--(Newsfile Corp. - October 13, 2026) - Gossan Resources Limited (TSXV: GSS) (FSE: GSR) (XETRA: GSR) (the "Company" or "Gossan") is pleased to announce a non-brokered private placeme...
October 13, 2026
Melexis NV (Euronext Brussels: MELE)Press release – Regulated informationTessenderlo (BE), 13 October 2026 – 07:00 CET Disclosure of transparency notification (article 14, first paragraph, of the Law ...
October 13, 2026
Energy markets are back in the spotlight as Brent and WTI react to Middle East risk, Russia’s shifting fuel exports and fresh forecasts from Goldman Sachs that keep supply worries alive. Price swings ...
October 12, 2026
PARIS, October 12, 2026--Regulatory News: Gecina (Paris:GFC):
October 12, 2026
Ramsay Générale de Santé has spent the past few years under pressure, yet the shares have climbed modestly over the past year, which puts a fresh spotlight on what investors are paying for its sales t...
October 10, 2026
Ramsay Générale de Santé (ENXTPA:GDS) has called a board meeting for 6 October 2026 to review the auditors’ certification report on its consolidated accounts, a routine governance step that remains im...
October 10, 2026